Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 90 member A7 (FAM90A7) is a member of the FAM90A gene family, which is primate-specific and believed to have arisen from repeated duplications and rearrangements[1]. While sometimes denominated as a "pseudogene," FAM90A7 is listed in genomic databases as a protein-coding gene, but there is no known molecular function, biological role, or disease association. No drugs or therapeutic interventions are described or in development targeting FAM90A7, and it is not considered a validated therapeutic target or biomarker. Because its status oscillates between "putative protein" and "pseudogene," and there is a lack of experimental evidence for functional protein products or biological roles, FAM90A7 is not regarded as a meaningful molecular target in drug discovery or clinical research[1][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 90 member A7 (FAM90A7).